Publications by authors named "Tetsuya Toyama"

Claim this Profile
C
Clinical trial of cisplatin-conjugated gelatin microspheres for patients with hepatocellular carcinoma.
Tetsuya Toyama, Norihisa Nitta, Shinichi Ohta, Toyohiko Tanaka, Yukihiro Nagatani

Jpn J Radiol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An initial clinical study on the efficacy of cisplatin-releasing gelatin microspheres for metastatic liver tumors.
Norihisa Nitta, Shinichi Ohta, Toyohiko Tanaka, Ryutaro Takazakura, Tetsuya Toyama

Eur J Radiol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, reduces hepatic steatosis and lipid peroxidation in fatty liver Shionogi mice with hereditary fatty liver.
Yuichi Harano, Kohichiroh Yasui, Tetsuya Toyama, Tomoki Nakajima, Hironori Mitsuyoshi

Liver Int· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PPARalpha ligands activate antioxidant enzymes and suppress hepatic fibrosis in rats.
Tetsuya Toyama, Hideki Nakamura, Yuichi Harano, Norihito Yamauchi, Atsuhiro Morita

Biochem Biophys Res Commun· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics and prevalence of GB virus C, SEN virus, and HFE gene mutation in Japanese patients with nonalcoholic steatohepatitis.
Norihito Yamauchi, Yoshito Itoh, Yasuhito Tanaka, Masashi Mizokami, Masahito Minami, Tetsuya Toyama

J Gastroenterol· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activated Kupffer cells play an important role in intra-hepatic Th1-associated necro-inflammation in Concanavalin A-induced hepatic injury in mice.
Atsuhiro Morita, Yoshito Itoh, Tetsuya Toyama, Hideki Fujii, Kenichi Nishioji

Hepatol Res· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of YMDD mutant using a novel sensitive method in chronic liver disease type B patients before and during lamivudine treatment.
Toshihiko Kirishima, Takeshi Okanoue, Yukiko Daimon, Yoshito Itoh, Hideki Nakamura, Tetsuya Toyama

J Hepatol· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transient biochemical response in interferon therapy decreases the development of hepatocellular carcinoma for five years and improves the long-term survival of chronic hepatitis C patients.
Takeshi Okanoue, Yoshito Itoh, Toshihiko Kirishima, Yukiko Daimon, Tetsuya Toyama

Hepatol Res· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis